Tetraphase

La Jolla to acquire Tetraphase Pharma
Seeking Alpha
Wed, 06/24/20 - 10:24 am
La Jolla Pharmaceutical
M&A
Tetraphase
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Xconomy
Tue, 06/9/20 - 11:24 pm
Melinta Therapeutics
Tetraphase
M&A
antibiotics
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
Fri, 06/5/20 - 11:01 am
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
Mon, 03/16/20 - 11:02 am
antibiotics
Tetraphase
M&A
AcelRx
Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M
Endpoints
Fri, 07/28/17 - 10:38 pm
Idorsia
ACT-541468
insomnia
Tetraphase
​How Paratek hopes to succeed in antibiotics despite Tetraphase’s fail
Bizjournals.com
Wed, 10/14/15 - 09:17 am
Paratek
Tetraphase
antibiotics
omadacycline
FDA
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
4 New Big FDA Decisions Expected in September
24/7 Wall St
Sat, 09/5/15 - 11:01 am
FDA
Tetraphase
VTI208
Vital Therapies
Conatus Pharmaceuticals
Lexicon Pharmaceuticals
telotristat